Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00081315. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II, Randomized, Double-Blind, Multicenter Trial of Subcutaneous Amifostine (Ethyol®) Versus Placebo in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to assess the activity of subcutaneous (SC) amifostine on the incidence and severity of acute radiochemotherapy-induced esophagitis in patients with unresectable Stage IIIA or IIIB non-small cell lung cancer (NSCLC) receiving combined modality therapy.
Study identification
- NCT ID
- NCT00081315
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 130 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2003 (Type not available)
- Primary completion
- Not listed
- Completion
- Aug 2006 (Actual)
- Last update posted
- Aug 21, 2007
2003 – 2006
United States locations
- U.S. sites
- 24
- U.S. states
- 13
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cedars Sanai | Los Angeles | California | 90048 | — |
| Radiation Oncology Center | Sacramento | California | 95816 | — |
| The Center for Cancer Care | Torrington | Connecticut | 06790 | — |
| Florida Wellcare Alliance | Inverness | Florida | 34452 | — |
| Florida Community Cancer Center | New Port Richey | Florida | 34652 | — |
| Ormand Memorial Cancer Center | Ormand Beach | Florida | 32174 | — |
| Sarasota Memorial Hospital | Sarasota | Florida | 34239 | — |
| University Community Hospital-Center for Cancer Care | Tampa | Florida | 33613 | — |
| University of Kentucky | Lexington | Kentucky | 40536-0293 | — |
| St. Agnes Health Care | Baltimore | Maryland | 21229 | — |
| Center for Cancer & Blood Disorders | Bethesda | Maryland | 20817 | — |
| Chesapeake Oncology-Hematology Associates | Glen Burnie | Maryland | 21061 | — |
| St. John's Medical Research | Springfield | Missouri | 65807 | — |
| Cooper University Hospital | Camden | New Jersey | 08103 | — |
| Long Island Jewish Medical Center | New Hyde Park | New York | 11040 | — |
| Beth Israel Hospital | New York | New York | 10003 | — |
| Upstate NY Cancer R&E Foundation | Rochester | New York | 14623 | — |
| New Hanover Radiation | Wilmington | North Carolina | 28401 | — |
| Cancer Center of Upper Delaware Valley | Milford | Pennsylvania | 18337 | — |
| Montgomery Cancer Center | Norristown | Pennsylvania | 19401 | — |
| Charleston Cancer Center | Charleston | South Carolina | 29406 | — |
| The Center for Radiation Oncology | Danville | Virginia | 24541 | — |
| Providence Everett Medical Center | Everett | Washington | 98201 | — |
| Valley Medical Center | Renton | Washington | 98055 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00081315, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 21, 2007 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00081315 live on ClinicalTrials.gov.